Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
December 18, 2007
Patent Application Number
10525709
Date Filed
August 26, 2003
Patent Primary Examiner
Patent abstract
Obtaining the crystal of 4,6-dimethyl-4′-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]nicotinanilide having excellent activity of inhibiting Ca2+ release-activated Ca2+ channel and suppressing IL-2 production to find that the compound includes the presence of two types of polymorphic crystals and that any of the crystals is preferable as a raw material for producing pharmaceutical compositions.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
